Funding Rounds
Haya Therapeutics Series D Round, September 2024
Haya TherapeuticsRNA-guided regulatory genome targeting therapeutics developer for chronic diseases.
Summary
Stage: Series D
Raised Amount: $1000.00M
Raised Date: 2024-09-04
Stage: Series D
Raised Amount: $1000.00M
Raised Date: 2024-09-04